Abstract
The cellular infiltrates of certain inflammatory processes found in parasitic infection or in allergic diseases consist predominantly of eosinophilic granulocytes, often in association with activated T cells. This suggests the existence of chemotactic agonists specific for eosinophils and lymphocyte subsets devoid of neutrophil-activating properties. We therefore examined four members of the intercrine/chemokine superfamily of cytokines (monocyte chemotactic peptide 1 [MCP-1], RANTES, macrophage inflammatory protein 1 alpha [MIP-1 alpha], and MIP-1 beta), which do not activate neutrophils, for their ability to affect different eosinophil effector functions. RANTES strongly attracted normal human eosinophils by a chemotactic rather than a chemokinetic mechanism with a similar efficacy as the most potent chemotactic myeloid cell agonist, C5a. MIP-1 alpha also induced eosinophil migration, however, with lower efficacy. RANTES and MIP-1 alpha induced eosinophil cationic protein release in cytochalasin B-treated eosinophils, but did not promote leukotriene C4 formation by eosinophils, even after preincubation with interleukin 3 (IL-3), in contrast to other chemotactic agonists such as C5a and formyl-methionyl-leucyl-phenylalanine (FMLP). RANTES, but not MIP-1 alpha, induced a biphasic chemiluminescence response, however, of lower magnitude than C5a. RANTES and MIP-1 alpha both promoted identical transient changes in intracellular free calcium concentration ([Ca2+]i), with kinetics similar to those induced by chemotactic peptides known to interact with G protein-coupled receptors. No cross-desensitization towards other peptide agonists (e.g., C5a, IL-8, FMLP) was observed, suggesting the presence of specific receptors. Despite its weaker eosinophil-activating properties, MIP-1 alpha was at least 10 times more potent on a molar basis than RANTES at inducing [Ca2+]i changes. Interestingly, RANTES deactivated the MIP-1 alpha-induced [Ca2+]i changes, while the RANTES response was preserved after MIP-1 alpha stimulation. MCP-1, a potent monocyte chemoattractant and basophil agonist, as well as MIP-1 beta, a peptide with pronounced homology to MIP-1 alpha, did not activate the eosinophil functions tested. Our results indicate that RANTES and MIP-1 alpha are crucial mediators of inflammatory processes in which eosinophils predominate.
MeSH Terms
Blood Proteins/biosynthesis
Chemokine CCL3
Chemokine CCL4
Chemokine CCL5
Chemotaxis, Leukocyte/drug effects
Complement C5a/pharmacology
Cytokines/pharmacology
Eosinophil Granule Proteins
Eosinophils/drug effects,physiology
Escherichia coli/genetics
Humans
In Vitro Techniques
Kinetics
Luminescent Measurements
Lymphokines/pharmacology
Macrophage Inflammatory Proteins
Monokines/pharmacology
N-Formylmethionine Leucyl-Phenylalanine/pharmacology
Recombinant Proteins/pharmacology
Ribonucleases
SRS-A/biosynthesis,blood
Superoxides/blood
Chemicals
Blood Proteins
Chemokine CCL3
Chemokine CCL4
Chemokine CCL5
Cytokines
Eosinophil Granule Proteins
Lymphokines
Macrophage Inflammatory Proteins
Monokines
Recombinant Proteins
SRS-A
Superoxides
N-Formylmethionine Leucyl-Phenylalanine
Complement C5a
Ribonucleases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Rot A
Institute of Clinical Immunology, Bern, Switzerland.
Krieger M
Brunner T
Bischoff S C
Schall T J
Dahinden C A
References (27)
27 references, click to expand
-
Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes.
J Immunol. 1990 Jul 1;145(1):292-7
PMID: 2162890
-
Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.
J Clin Invest. 1991 Jun;87(6):2012-7
PMID: 2040692
-
Neutrophil-activating properties of the melanoma growth-stimulatory activity.
J Exp Med. 1990 May 1;171(5):1797-802
PMID: 2185333
-
Human monocyte chemoattractant protein-1 (MCP-1).
Immunol Today. 1990 Mar;11(3):97-101
PMID: 2186747
-
Leukocyte specificity and binding of human neutrophil attractant/activation protein-1.
J Immunol. 1990 Feb 15;144(4):1323-30
PMID: 2406341
-
The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils.
J Exp Med. 1989 Nov 1;170(5):1787-92
PMID: 2478657
-
A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils.
Biochem Biophys Res Commun. 1989 Mar 31;159(3):969-75
PMID: 2522778
-
The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.
Science. 1989 Mar 17;243(4897):1464-6
PMID: 2648569
-
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
J Clin Invest. 1989 Oct;84(4):1045-9
PMID: 2677047
-
Chemiluminescence detection of H2O2 produced by human neutrophils during the respiratory burst.
Anal Biochem. 1987 Sep;165(2):371-8
PMID: 3425906
-
Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects.
Blood. 1992 Jun 1;79(11):2952-9
PMID: 1316789
-
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.
J Clin Invest. 1992 Mar;89(3):723-8
PMID: 1371775
-
Airway eosinophils and lymphocytes in asthma. Birds of a feather?
Am Rev Respir Dis. 1992 Jun;145(6):1246-8
PMID: 1375819
-
Monocyte chemotactic protein 1 is a potent activator of human basophils.
J Exp Med. 1992 May 1;175(5):1271-5
PMID: 1569397
-
Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils.
Blood. 1992 May 15;79(10):2662-9
PMID: 1586715
-
Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3.
Blood. 1991 Jun 15;77(12):2694-700
PMID: 1646045
-
An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils.
J Immunol Methods. 1991 Dec 15;145(1-2):105-10
PMID: 1662676
-
T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma.
J Immunol. 1991 Mar 15;146(6):1829-35
PMID: 1672334
-
UCHL1+ (CD45RO+) 'memory' T cells predominate in the CD4+ cellular infiltrate associated with allergen-induced late-phase skin reactions in atopic subjects.
Clin Exp Immunol. 1991 May;84(2):270-4
PMID: 1673877
-
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES.
Nature. 1990 Oct 18;347(6294):669-71
PMID: 1699135
-
Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists.
J Exp Med. 1990 Dec 1;172(6):1577-82
PMID: 1701820
-
Biology of the RANTES/SIS cytokine family.
Cytokine. 1991 May;3(3):165-83
PMID: 1715772
-
Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8.
J Exp Med. 1991 Dec 1;174(6):1355-62
PMID: 1744577
-
CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration.
J Exp Med. 1991 Jun 1;173(6):1521-8
PMID: 1851800
-
IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists.
J Immunol. 1991 Dec 1;147(11):3855-61
PMID: 1940371
-
Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils.
J Biol Chem. 1991 Jun 5;266(16):10666-71
PMID: 2037605
-
Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity.
J Exp Med. 1990 Apr 1;171(4):1091-100
PMID: 2182761